213 related articles for article (PubMed ID: 25660368)
1. Treatment of basal cell carcinoma in Scandinavia: evidence or eminence based?
Helsing P; Gjersvik P; Tarstedt M
Int J Dermatol; 2015 Sep; 54(9):1030-3. PubMed ID: 25660368
[TBL] [Abstract][Full Text] [Related]
2. [Therapy of basal cell carcinoma].
Schmitz L; Dirschka T
Hautarzt; 2016 Jun; 67(6):483-99. PubMed ID: 27206448
[TBL] [Abstract][Full Text] [Related]
3. Update of the European guidelines for basal cell carcinoma management.
Trakatelli M; Morton C; Nagore E; Ulrich C; Del Marmol V; Peris K; Basset-Seguin N;
Eur J Dermatol; 2014; 24(3):312-29. PubMed ID: 24723647
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines.
Peris K; Fargnoli MC; Garbe C; Kaufmann R; Bastholt L; Seguin NB; Bataille V; Marmol VD; Dummer R; Harwood CA; Hauschild A; Höller C; Haedersdal M; Malvehy J; Middleton MR; Morton CA; Nagore E; Stratigos AJ; Szeimies RM; Tagliaferri L; Trakatelli M; Zalaudek I; Eggermont A; Grob JJ;
Eur J Cancer; 2019 Sep; 118():10-34. PubMed ID: 31288208
[TBL] [Abstract][Full Text] [Related]
5. Basal cell carcinoma: an evidence-based treatment update.
Clark CM; Furniss M; Mackay-Wiggan JM
Am J Clin Dermatol; 2014 Jul; 15(3):197-216. PubMed ID: 24733429
[TBL] [Abstract][Full Text] [Related]
6. Differences in Rate of Complete Excision of Basal Cell Carcinoma by Dermatologists, Plastic Surgeons and General Practitioners: A Large Cross-Sectional Study.
Ramdas K; van Lee C; Beck S; Bindels P; Noordhoek Hegt V; Pardo L; Versnel S; Nijsten T; van den Bos R
Dermatology; 2018; 234(3-4):86-91. PubMed ID: 30086541
[TBL] [Abstract][Full Text] [Related]
7. Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up.
Roozeboom MH; Aardoom MA; Nelemans PJ; Thissen MR; Kelleners-Smeets NW; Kuijpers DI; Mosterd K
J Am Acad Dermatol; 2013 Aug; 69(2):280-7. PubMed ID: 23566914
[TBL] [Abstract][Full Text] [Related]
8. Physicians' opinions and clinical practice patterns for actinic keratosis management in Italy.
Peris K; Neri L; Calzavara Pinton P; Catricalà C; Pellacani G; Pimpinelli N; Peserico A
G Ital Dermatol Venereol; 2014 Apr; 149(2):185-92. PubMed ID: 24819638
[TBL] [Abstract][Full Text] [Related]
9. Choosing treatments for patients: the not so simple case of basal cell carcinoma.
Rees J
Acta Derm Venereol; 2009; 89(5):450-2. PubMed ID: 19734965
[No Abstract] [Full Text] [Related]
10. Factors influencing current low-value follow-up care after basal cell carcinoma and suggested strategies for de-adoption: a qualitative study.
van Egmond S; Wakkee M; van Rengen A; Bastiaens MT; Nijsten T; Lugtenberg M
Br J Dermatol; 2019 Jun; 180(6):1420-1429. PubMed ID: 30597525
[TBL] [Abstract][Full Text] [Related]
11. Accuracy and predictors of basal cell carcinoma diagnosis.
Schwartzberg JB; Elgart GW; Romanelli P; Fangchao M; Federman DG; Kirsner RS
Dermatol Surg; 2005 May; 31(5):534-7. PubMed ID: 15962736
[TBL] [Abstract][Full Text] [Related]
12. The incidence of metastatic basal cell carcinoma (mBCC) in Denmark, 1997-2010.
Nguyen-Nielsen M; Wang L; Pedersen L; Olesen AB; Hou J; Mackey H; McCusker M; Basset-Seguin N; Fryzek J; Vyberg M
Eur J Dermatol; 2015; 25(5):463-8. PubMed ID: 26105129
[TBL] [Abstract][Full Text] [Related]
13. Histology-based treatment of basal cell carcinoma.
Mosterd K; Arits AH; Thissen MR; Kelleners-Smeets NW
Acta Derm Venereol; 2009; 89(5):454-8. PubMed ID: 19734968
[TBL] [Abstract][Full Text] [Related]
14. Basal cell carcinoma follow-up practices by dermatologists: a national survey.
Bower CP; Lear JT; de Berker DA
Br J Dermatol; 2001 Dec; 145(6):949-56. PubMed ID: 11899149
[TBL] [Abstract][Full Text] [Related]
15. [What is new in basal cell carcinoma?].
Heppt M; von Braunmühl T; Berking C
Hautarzt; 2016 Nov; 67(11):876-883. PubMed ID: 27654826
[TBL] [Abstract][Full Text] [Related]
16. Management of basal cell carcinoma by surveyed dermatologists in Scotland.
Gudi V; Ormerod AD; Dawn G; Green C; MacKie RM; Douglas WS; Gupta G;
Clin Exp Dermatol; 2006 Sep; 31(5):648-52. PubMed ID: 16901303
[TBL] [Abstract][Full Text] [Related]
17. Identifying locally advanced basal cell carcinoma eligible for treatment with vismodegib: an expert panel consensus.
Peris K; Licitra L; Ascierto PA; Corvò R; Simonacci M; Picciotto F; Gualdi G; Pellacani G; Santoro A
Future Oncol; 2015; 11(4):703-12. PubMed ID: 25686123
[TBL] [Abstract][Full Text] [Related]
18. Nonsurgical treatment options for basal cell carcinoma - focus on advanced disease.
Goldenberg G; Hamid O
J Drugs Dermatol; 2013 Dec; 12(12):1369-78. PubMed ID: 24301238
[TBL] [Abstract][Full Text] [Related]
19. The current and future role of general practitioners in skin cancer care: an assessment of 268 general practitioners.
van Rijsingen MC; van Bon B; van der Wilt GJ; Lagro-Janssen AL; Gerritsen MJ
Br J Dermatol; 2014 Jun; 170(6):1366-8. PubMed ID: 24601950
[TBL] [Abstract][Full Text] [Related]
20. Topical and systemic medical treatments of basal cell carcinoma.
Sollena P; Del Regno L; Fargnoli MC; Peris K
G Ital Dermatol Venereol; 2015 Aug; 150(4):429-34. PubMed ID: 26086413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
